Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016266
Filing Date
2022-11-03
Accepted
2022-11-03 16:25:35
Documents
72
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20220930x10q.htm   iXBRL 10-Q 2515518
2 EX-10.1 rigl-20220930xex10d1.htm EX-10.1 1343935
3 EX-10.2 rigl-20220930xex10d2.htm EX-10.2 899243
4 EX-31.1 rigl-20220930xex31d1.htm EX-31.1 15898
5 EX-31.2 rigl-20220930xex31d2.htm EX-31.2 16784
6 EX-32.1 rigl-20220930xex32d1.htm EX-32.1 9080
7 GRAPHIC rigl-20220930x10q004.jpg GRAPHIC 122539
8 GRAPHIC rigl-20220930xex10d2001.jpg GRAPHIC 7554
  Complete submission text file 0001558370-22-016266.txt   11660396

Data Files

Seq Description Document Type Size
9 EX-101.SCH rigl-20220930.xsd EX-101.SCH 52104
10 EX-101.CAL rigl-20220930_cal.xml EX-101.CAL 52004
11 EX-101.DEF rigl-20220930_def.xml EX-101.DEF 218981
12 EX-101.LAB rigl-20220930_lab.xml EX-101.LAB 472066
13 EX-101.PRE rigl-20220930_pre.xml EX-101.PRE 345778
66 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20220930x10q_htm.xml XML 1644953
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 221358440
SIC: 2834 Pharmaceutical Preparations